Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Reversible activation

Alters norepinephrine turnover Reduced j8-adrenergic binding and activity Reverses age-related decline in o2 adrengic receptors GABA Elevation of GABA levels... [Pg.162]

Taylor M, Le Goff L, Harris A, Malone E, Allen JE, Maizels RM Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 2005 174 4924-4933. [Pg.122]

Another receptor, LXR (Liver X receptor), also exists in alpha and beta forms, and acts as a receptor for cholesterol and its degradation products, which accumulate when cholesterol levels are high. LXRs are expressed in the liver and lower digestive tract, where they regulate cholesterol and bile-acid homeostasis. LXR-beta activates reverse cholesterol transport from the periphery to the liver. LXR-alpha, which is found in the liver, promotes catabolism in the liver and drives catabolism of cholesterol to BAs. Its activation in the liver increases... [Pg.5]

Qiolinesterases from various sources Quaternary heterocyclic oximes inhibit enzyme activity reversibly 127-131... [Pg.635]

We performed a systematic molecular and behavioural screen to identify locomotor factors secreted by the SCN. To find secreted factors not previously documented in the SCN, we screened a hamster SCN cDNA library in a yeast secretiomtrap system (Klein et al 1996). We then carried out a behavioural screen in which newly identified and previously documented (Earnest et al 1999, Miller et al 1996, Ma et al 1992) SCN factors were tested for an effect on circadian locomotor activity by constant infusion into the 3rd ventricle of hamsters for 2 to 3 weeks (Kramer et al 2001). In general, constant infusion of a SCN locomotor factor should alter locomotor activity reversibly without affecting the underlying SCN circadian clock. A locomotor inhibitory factor, for example, should block locomotor activity for the duration of the infusion. Because the SCN clock should not be affected, the circadian rhythm of locomotor activity should reappear with its expected phase and period upon cessation of the infusion, fn contrast, constant infusion of SCN factors involved only in outputs other than locomotor activity should have no effect on locomotor behaviour. [Pg.252]

Recently, a simple solubilization theory has been developed to predict the equilibrium distribution of zwitterionic amino acids from information of the initial conditions of the system. This theory is based on the chemical and electrostatic interactions between the amino acids and active reverse micellar interface. The predictions of the model are in excellent agreement with the experimental results [201]. [Pg.157]

The harmala alkaloids harmaline (368 X = NH) and harmi.ne (369 X = NH) are active reversible inhibitors of monoamine oxidase (MAO). Benzo[ Jthiophene analogs of harmaline (368 X = S) and harmine (369 X = S), when tested in vitro as inhibitors of rat liver MAO, showed that (368 X = S) was 50 times more potent than harmaline, but (369 X = NH or S) were equivalent in potency. The replacement of the indolic nitrogen by sulfur greatly increased the lipid solubility of the molecule, which was reflected in the physiological disposition of the two analogs. [Pg.913]

The large photospeed variations realized in solutions do not appear to carry over into film-based compositions, and in fact activity reversals are found. This is most easily seen in Table 11, in which additional examples from our own work are... [Pg.461]

Didanosine is a synthetic purine nucleoside analog that inhibits the activity of reverse transcriptase in HIV-1, HIV-2, other retroviruses and zidovudine-resistant strains. A nucleobase carrier helps transport it into the cell where it needs to be phosphorylated by 5 -nucleoiidase and inosine 5 -monophosphate phosphotransferase to didanosine S -monophosphate. Adenylosuccinate synthetase and adenylosuccinate lyase then convert didanosine 5 -monophosphate to dideoxyadenosine S -monophosphate, followed by its conversion to diphosphate by adenylate kinase and phosphoribosyl pyrophosphate synthetase, which is then phosphorylated by creatine kinase and phosphoribosyl pyrophosphate synthetase to dideoxyadenosine S -triphosphate, the active reverse transcriptase inhibitor. Dideoxyadenosine triphosphate inhibits the activity of HIV reverse transcriptase by competing with the natural substrate, deoxyadenosine triphosphate, and its incorporation into viral DNA causes termination of viral DNA chain elongation. It is 10-100-fold less potent than zidovudine in its antiviral activity, but is more active than zidovudine in nondividing and quiescent cells. At clinically relevant doses, it is not toxic to hematopoietic precursor cells or lymphocytes, and the resistance to the drug results from site-directed mutagenesis at codons 65 and 74 of viral reverse transcriptase. [Pg.178]

When considering the effect of temperature on multiphonon processes, one should take into account stimulated phonon-assisted transitions ([20,21]) and include thermally activated reversed transitions. Account of these factors gives... [Pg.164]

Two further perspectives on the use of tetracychnes in rheumatoid arthritis have been pubhshed (14,15). In addition to an effect on matrix metalloproteinases, the authors focused on a potential antiarthritic action of tetracyclines by their effects in the interaction between the generation of nitric oxide, matrix metalloproteinase release, and chondrocyte apoptosis. Both minocychne and doxycycline inhibit the production of nitric oxide from human cartilage and murine macrophages (16) in concentrations that are achieved in vivo. The authors suggested that tetracyclines may have several potential chondroprotective effects direct inhibition of matrix metalloproteinase activity and, by inhibition of nitric oxide production, further reduction of matrix metalloproteinase activity, reversal of reduced matrix synthesis, and reduced chondrocyte apoptosis. [Pg.3331]

In Fischer 344 rats, exposure to cumene vapor for 13 weeks resulted in mild toxicity at 1200 ppm, minimal effects at 500 ppm, and no-observed effects at 50 and 100 ppm the main effects were reversible decreased activity, reversible organ weight changes, and male rat renal hyaline droplet formation, which is not believed to be relevant to humans. Neurotoxi-cological effects were not observed in this study, which included complete batteries of functional and motor activity tests and neurohistopathology. [Pg.691]

Enzyme inhibitors are species that cause a decrease in the activity of an enzyme. Inhibitors usually interact with the enzyme itself, forming enzyme-inhibitor (E I) complexes, but in a few cases, the inhibition mechanism involves reaction with one of the substrates. Inhibition is considered to be reversible if the enzyme recovers its activity when the inhibitor is removed, and irreversible if the inhibitor causes a permanent loss of activity. Reversible inhibition affects the specific activity and apparent Michaelis-Menten parameters for the enzyme, while irreversible inhibition (where the E I complex formation is irreversible) simply decreases the concentration of active enzyme present in the sample. A well-known example of irreversible inhibition is the effect of nerve gas on the enzyme cholinesterase. [Pg.33]

Figure 49-1 Bone remodeling.The bone remodeling sequence includes activation, reversal, formation, and resting phases. Reproduced from Baron R 2003 General Principles of Bone Biology. In Favus M (ed.) The Primer on the Metabolic Bone D/seoses and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington DC, USA, pp. I 8 with permission of the American Society for Bone and Mineral Research. Figure 49-1 Bone remodeling.The bone remodeling sequence includes activation, reversal, formation, and resting phases. Reproduced from Baron R 2003 General Principles of Bone Biology. In Favus M (ed.) The Primer on the Metabolic Bone D/seoses and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington DC, USA, pp. I 8 with permission of the American Society for Bone and Mineral Research.
Centrally active, reversible acetylcholinesterase inhibitor increases the acetylcholine available for synaptic transmission in the CNS APOE, CHAT CHAT, ACHE, BCHE... [Pg.473]

Although phospholipid bilayers are better mimics of biomembranes than are micelles, there are few reliable quantitative data on flavonoid antioxidant activities in lipid bilayers. Terao and coworkers compared the antioxidant efficiency of quercetin and catechins (epicatechin and epicatechin gallate) with that of a-Toc in egg yolk PC liposomes using initiation by the water-soluble initiator, ABAP, and analysis of hydroperoxide formation and antioxidant consumption by HPLC. Based on the length of the induction periods and the profile of suppressed hydroperoxide formation, they concluded that quercetin and the catechins were more efficient antioxidants than a-Toc in these bilayers. Apparently the unique behavior of a-Toc in bUayers is responsible for these results (vide supra). In hexane and alcohols solution during suppressed peroxidation of methyl linoleate, the relative antioxidant activities reversed so that the flavonoids were 5-20 times less active... [Pg.894]

The reversibility of binding to the bilayer can be measured in a so-called hopping experiment [3]. In this assay on intervesicular transfer, the activity of synthetic ion channels or pores is measured in LUVs as described (Section 11.2.2). Then, fresh LUVs loaded with fluorescent probes are added for a second time. Inactivity in this second round demonstrates irreversible, activity reversible binding of synthetic ion channels or pores to the bilayer membrane of the initially added LUVs. [Pg.414]

These considerations provide a strong argument and rationale for discovery and development of inhibitors of RND transporters from Gram-negative bacteria that could be used in conjunction vdth antibiotics. Such inhibitors would increase antibacterial potency, expand the spectrum of antibacterial activity, reverse resistance... [Pg.140]


See other pages where Reversible activation is mentioned: [Pg.1019]    [Pg.37]    [Pg.99]    [Pg.15]    [Pg.59]    [Pg.241]    [Pg.92]    [Pg.203]    [Pg.77]    [Pg.417]    [Pg.625]    [Pg.200]    [Pg.284]    [Pg.145]    [Pg.164]    [Pg.148]    [Pg.1019]    [Pg.3924]    [Pg.61]    [Pg.149]    [Pg.1027]    [Pg.1592]    [Pg.883]    [Pg.142]    [Pg.338]    [Pg.643]    [Pg.101]    [Pg.207]    [Pg.643]    [Pg.508]    [Pg.173]    [Pg.29]   
See also in sourсe #XX -- [ Pg.261 ]




SEARCH



Activation Energy of the Reverse Reaction

Activation eneigy, reverse

Activation energy, reverse

Activation, reversible processes

Apparent Heat of Activation at the Reversible Potential

Cholinesterase reversibility of activity

Electron transfer, activation control reversible

Oxidative activation microscopic reversibility

Polymerization reversible activation

Problem Formation of active reverse transcriptase dimers

Reverse activation barrier

Reverse activities of CDases

Reverse transcriptase activity assay

Reverse transcriptase nuclease activity

Reversible Reaction at the Active Site

Reversible activation energies

Reversible chain transfer catalyzed activation processes

Reversible enzyme reaction, active site

© 2024 chempedia.info